Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP924396.RAvEhYbh1pJXAoYGhGCpEZYObVOtpd3T-LSAUXBHfkSg0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP924396.RAvEhYbh1pJXAoYGhGCpEZYObVOtpd3T-LSAUXBHfkSg0130_assertion type Assertion NP924396.RAvEhYbh1pJXAoYGhGCpEZYObVOtpd3T-LSAUXBHfkSg0130_head.
- NP924396.RAvEhYbh1pJXAoYGhGCpEZYObVOtpd3T-LSAUXBHfkSg0130_assertion description "[Human epidermal growth factor receptor 2 (HER2) (neu/ERBB2) is overexpressed on many types of cancer cells, including gastric cancer cells; HER2 overexpression has been associated with metastasis and poor prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP924396.RAvEhYbh1pJXAoYGhGCpEZYObVOtpd3T-LSAUXBHfkSg0130_provenance.
- NP924396.RAvEhYbh1pJXAoYGhGCpEZYObVOtpd3T-LSAUXBHfkSg0130_assertion evidence source_evidence_literature NP924396.RAvEhYbh1pJXAoYGhGCpEZYObVOtpd3T-LSAUXBHfkSg0130_provenance.
- NP924396.RAvEhYbh1pJXAoYGhGCpEZYObVOtpd3T-LSAUXBHfkSg0130_assertion SIO_000772 21925125 NP924396.RAvEhYbh1pJXAoYGhGCpEZYObVOtpd3T-LSAUXBHfkSg0130_provenance.
- NP924396.RAvEhYbh1pJXAoYGhGCpEZYObVOtpd3T-LSAUXBHfkSg0130_assertion wasDerivedFrom befree-2016 NP924396.RAvEhYbh1pJXAoYGhGCpEZYObVOtpd3T-LSAUXBHfkSg0130_provenance.
- NP924396.RAvEhYbh1pJXAoYGhGCpEZYObVOtpd3T-LSAUXBHfkSg0130_assertion wasGeneratedBy ECO_0000203 NP924396.RAvEhYbh1pJXAoYGhGCpEZYObVOtpd3T-LSAUXBHfkSg0130_provenance.